These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34455956)

  • 1. Targeting Abnormal PI3K/AKT/mTOR Signaling in Intracerebral Hemorrhage: A Systematic Review on Potential Drug Targets and Influences of Signaling Modulators on Other Neurological Disorders.
    Jadaun KS; Sharma A; Siddiqui EM; Mehan S
    Curr Rev Clin Exp Pharmacol; 2022; 17(3):174-191. PubMed ID: 34455956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective Effect of Chrysophanol as a PI3K/AKT/mTOR Signaling Inhibitor in an Experimental Model of Autologous Blood-induced Intracerebral Hemorrhage.
    Jadaun KS; Mehan S; Sharma A; Siddiqui EM; Kumar S; Alsuhaymi N
    Curr Med Sci; 2022 Apr; 42(2):249-266. PubMed ID: 35079960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural products attenuate PI3K/Akt/mTOR signaling pathway: A promising strategy in regulating neurodegeneration.
    Fakhri S; Iranpanah A; Gravandi MM; Moradi SZ; Ranjbari M; Majnooni MB; Echeverría J; Qi Y; Wang M; Liao P; Farzaei MH; Xiao J
    Phytomedicine; 2021 Oct; 91():153664. PubMed ID: 34391082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PI3K-AKT/mTOR signaling in the prevention of autism.
    Sharma A; Mehan S
    Neurochem Int; 2021 Jul; 147():105067. PubMed ID: 33992742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance.
    Ediriweera MK; Tennekoon KH; Samarakoon SR
    Semin Cancer Biol; 2019 Dec; 59():147-160. PubMed ID: 31128298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone attenuates neurological deficits and exerts a protective effect on damaged axons via the PI3K/AKT/mTOR-dependent pathway in a mouse model of intracerebral hemorrhage.
    Liu C; Gao W; Zhao L; Cao Y
    Aging (Albany NY); 2022 Mar; 14(6):2574-2589. PubMed ID: 35305084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells.
    Lee JE; Lim MS; Park JH; Park CH; Koh HC
    Mol Neurobiol; 2016 Aug; 53(6):3771-3782. PubMed ID: 26143260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGB1/PI3K/Akt/mTOR Signaling Participates in the Pathological Process of Acute Lung Injury by Regulating the Maturation and Function of Dendritic Cells.
    Li R; Zou X; Huang H; Yu Y; Zhang H; Liu P; Pan S; Ouyang Y; Shang Y
    Front Immunol; 2020; 11():1104. PubMed ID: 32636835
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
    BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent studies on PI3K/AKT/mTOR signaling pathway in hematopoietic stem cells].
    Zhang YC; Cheng T; Yuan WP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):245-9. PubMed ID: 23484729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway.
    Zhang X; Shi H; Tang H; Fang Z; Wang J; Cui S
    Int J Mol Med; 2015 May; 35(5):1301-8. PubMed ID: 25760926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton.
    Zhang C; Yang N; Yang CH; Ding HS; Luo C; Zhang Y; Wu MJ; Zhang XW; Shen X; Jiang HL; Meng LH; Ding J
    PLoS One; 2009; 4(3):e4881. PubMed ID: 19293927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside.
    Martelli AM; Tazzari PL; Evangelisti C; Chiarini F; Blalock WL; Billi AM; Manzoli L; McCubrey JA; Cocco L
    Curr Med Chem; 2007; 14(19):2009-23. PubMed ID: 17691943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients.
    Martelli AM; Evangelisti C; Chiarini F; McCubrey JA
    Oncotarget; 2010 Jun; 1(2):89-103. PubMed ID: 20671809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy protects against PI3K/Akt/mTOR-mediated apoptosis of spinal cord neurons after mechanical injury.
    Wang Z; Zhou L; Zheng X; Chen G; Pan R; Li J; Liu W
    Neurosci Lett; 2017 Aug; 656():158-164. PubMed ID: 28739349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of the Role of the Epigenetic Regulatory Mechanisms of PI3K/Akt/mTOR Signaling Pathway in Human Malignancies.
    Mohite R; Doshi G
    Curr Cancer Drug Targets; 2024; 24(3):231-244. PubMed ID: 37526459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration.
    Heras-Sandoval D; Pérez-Rojas JM; Hernández-Damián J; Pedraza-Chaverri J
    Cell Signal; 2014 Dec; 26(12):2694-701. PubMed ID: 25173700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and importance of the PI3K/Akt/mTOR signaling pathway in hematologic malignancies.
    Kawauchi K; Ogasawara T; Yasuyama M; Otsuka K; Yamada O
    Anticancer Agents Med Chem; 2009 Nov; 9(9):1024-38. PubMed ID: 19663778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells.
    Nepstad I; Hatfield KJ; Grønningsæter IS; Reikvam H
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer.
    Yu L; Wei J; Liu P
    Semin Cancer Biol; 2022 Oct; 85():69-94. PubMed ID: 34175443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.